Latest News about LILLY DRN

Recent news which mentions LILLY DRN

< Previous 1 2 3 Next >

Trump says tariffs will accelerate reshoring, but experts say it's not that easy

April 05, 2025

Trump drops Biden's proposal for Medicare to cover obesity drugs like Wegovy and Zepbound

April 04, 2025

Europe's pharma industry braces for tariffs as carve-out hopes fade

April 02, 2025

Hims & Hers shares rise as company adds new weight-loss medications to platform

April 01, 2025

Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks

April 01, 2025

Healthy Returns: AstraZeneca cholesterol pill shows promise as race with Merck heats up

April 01, 2025

Eli Lilly sues two pharmacies making copycat Zepbound, Mounjaro

April 01, 2025

Novo Nordisk's diabetes pill slashes risk of cardiovascular complications by 14% after four years

March 29, 2025

Novo Nordisk defends disappointing next-gen obesity drug: 'It will be an important product'

March 28, 2025

Novo Nordisk says copycat compounders are hurting Wegovy sales, may take legal action

March 27, 2025

Healthy Returns: Novo Nordisk scoops up Chinese obesity drug to compete with Eli Lilly

March 25, 2025

5 things to know before the stock market opens Tuesday

March 25, 2025

Eli Lilly will soon release key data on its weight loss pill. Here's why it could be a game-changer

March 24, 2025

Novo Nordisk's next-gen obesity drug CagriSema had investors excited. Now they're not so sure

March 24, 2025

Beijing pledges greater market access as top global CEOs gather at the China Development Forum

March 24, 2025

Zepbound copycats remain online despite FDA ban

March 21, 2025

Roche and Zealand Pharma strike $5.3 billion deal for new obesity drug candidate

March 12, 2025

White House: Stock market plunge is not as 'meaningful' as business activity

March 10, 2025

Amgen starts two critical late-stage trials for weight loss drug MariTide

March 05, 2025

Novo Nordisk offers Wegovy for less than half the price through new direct-to-consumer pharmacy

March 05, 2025

Healthy Returns: AbbVie is the newest potential weight loss drug market player

March 04, 2025

Eli Lilly plans at least $27 billion in new U.S. manufacturing investments

February 26, 2025

Eli Lilly is selling higher-dose vials of Zepbound at a lower price to boost weight loss drug access

February 25, 2025

Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says

February 21, 2025

Eli Lilly aims to invest in 'big problems hiding in plain sight' using obesity windfall

February 20, 2025

From pills to new uses, here's what Eli Lilly’s top scientist sees as the future of weight loss drugs

February 20, 2025

Healthy Returns: Ozempic helps curb alcohol use in new study — and doctors are concerned about telehealth GLP-1s

February 19, 2025

Trump's reciprocal tariffs would hit these European Union products that Americans buy the hardest

February 13, 2025

5 things to know before the stock market opens Thursday

February 06, 2025

Eli Lilly to release late-stage data on next-generation weight loss drug retatrutide in 2025, earlier than expected

February 06, 2025

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.